Ameritas Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $30.4K | Sell |
|
|||||
|
2025
Q2 | $44.7K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $392K | Sell |
|
|||||
|
2024
Q2 | $400K | Buy |
|
|||||
|
2024
Q1 | $357K | Sell |
|
|||||
|
2023
Q4 | $371K | Buy |
|
|||||
|
2023
Q3 | $233K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $216K | Sell |
|
|||||
|
2022
Q4 | $211K | Sell |
|
|||||
|
2022
Q3 | $205K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $291K | Buy |
|
|||||
|
2021
Q4 | $208K | Buy |
|